AZD3965 drug could prove useful in treating small cell lung cancer Manchester scientists have shown that a new drug could prove useful in treating little cell lung cancer – the most aggressive form of lung cancer. Scientists from the Cancer Analysis UK Manchester Institute, structured at The University of part and Manchester of the Manchester Cancer Research Centre, teamed up with professionals at AstraZeneca, within a collaboration agreed in 2010 2010, to test a drug – known as AZD3965 – on little cell lung cancer cells. The extensive research, released in the journal Clinical Cancer Research, also helps recognize which individuals are most likely to respond to the treatment.This brand is famous in the world as the only one whose analog/digital watches feature an unrivalled six sound/vibration alarms which can be preset independently according to one’s plan or needs. Other than just alerting you to execute a certain task they are watches that can actually accentuate one’s outlook and may be worn to nearly every occasion with satisfaction. The reliability and efficiency of Almeda multi alarm watches represents the unrivalled knowledge in the design and development of top quality watches by previous Swiss watch top manager and designer, and today President of Almeda Time Products, Mr.